CardioNet Access
CardioNet PEMS
LifeWatch Connect
MedNet Access
INR Physician Portal
BioTel Research Cardiac Safety Portal
Improving the Quality of Care While Reducing Costs
Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.
4,000,000,000+
Processing over 4 billion heartbeats a day
1,000,000+
Monitoring over 1 Million patients per year
30,000+
Each month more than 30,000 physicians refer patients to our products
1,000,000+
Provided over 1 million reports to physicians with information for diagnosis and therapy management
50,000+
Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued
$300,000,000+
Over $300 million invested in the technology and service platform
BioTel Heart is the leading provider of remote cardiac monitoring diagnostic services.
Need help with your heart monitor?
Find product details, quick start guides and more at myheartmonitor.com.
BioTel Research is an industry leader in clinical trials testing services, monitoring, data, and scientific consulting.
Latest News
BioTelemetry, Inc. to Release Fourth Quarter 2019 Earnings Results on February 26, 2020
MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2019 earnings on Wednesday, February 26 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 26, 2020. The broadcast will be available through the investor information section of […]
February 18, 2020
The Apple Heart Study findings have been published in NEJM.
In the study, participants who received an irregular rhythm notification on the Apple Watch wore the BioTelemetry ECG patch recorder, ePatch™, for up to 7 days to confirm atrial fibrillation.
November 20, 2019
BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results
Exceeds Expectations Delivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2019. Quarter Highlights Recognized […]
November 5, 2019